Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ascletis Pharma, Inc. (HK:1672)
HKEX:1672
RESEARCH TOOLSreports
Ascletis Pharma, Inc. (1672) Stock Price & Analysis
0 Followers
1672 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$0.78 - HK$2.30
Previous CloseHK$0.8
Volume1.65M
Average Volume (3M)917.45K
Market Cap
HK$810.21M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.73
Next Earnings
Aug 19, 2024EPS Estimate
-HK$0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.15
Shares Outstanding1,012,758,000
10 Day Avg. Volume716,400
30 Day Avg. Volume917,448
Standard Deviation0.15
R-Squared0.10
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$3.80Price Target Upside375.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Ascletis Pharma, Inc. News
PremiumCompany Announcements
Ascletis Pharma Announces Share Buyback Plan
PremiumCompany Announcements
Ascletis Pharma’s Drug Shows Positive Trial ResultsOptions Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.46% Mutual Funds
0.04% Other Institutional Investors
99.50% Public Companies and
Individual Investors
1672 FAQ
What was Ascletis Pharma, Inc.’s price range in the past 12 months?
Ascletis Pharma, Inc. lowest stock price was HK$0.78 and its highest was HK$2.30 in the past 12 months.
What is Ascletis Pharma, Inc.’s market cap?
Currently, no data Available
When is Ascletis Pharma, Inc.’s upcoming earnings report date?
Ascletis Pharma, Inc.’s upcoming earnings report date is Aug 19, 2024 which is in 48 days.
How were Ascletis Pharma, Inc.’s earnings last quarter?
Ascletis Pharma, Inc. released its earnings results on Mar 25, 2024. The company reported -HK$0.129 earnings per share for the quarter, missing the consensus estimate of -HK$0.078 by -HK$0.051.
Is Ascletis Pharma, Inc. overvalued?
According to Wall Street analysts Ascletis Pharma, Inc.’s price is currently Undervalued.
Does Ascletis Pharma, Inc. pay dividends?
Ascletis Pharma, Inc. does not currently pay dividends.
What is Ascletis Pharma, Inc.’s EPS estimate?
Ascletis Pharma, Inc.’s EPS estimate is -HK$0.13.
How many shares outstanding does Ascletis Pharma, Inc. have?
Ascletis Pharma, Inc. has 1,012,758,000 shares outstanding.
What happened to Ascletis Pharma, Inc.’s price movement after its last earnings report?
Ascletis Pharma, Inc. reported an EPS of -HK$0.129 in its last earnings report, missing expectations of -HK$0.078. Following the earnings report the stock price went down -4.403%.
Which hedge fund is a major shareholder of Ascletis Pharma, Inc.?
Currently, no hedge funds are holding shares in HK:1672
---
Ascletis Pharma, Inc. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
HK$3.80 (375.00% Upside)
HK$3.80 (375.00% Upside)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Fundamentals
Return on Equity
-5.79%
Trailing 12-Months
Asset Growth
-8.06%
Trailing 12-Months
Company Description
Ascletis Pharma, Inc.
Ascletis Pharma Inc is a research and development driven biotechnology company which provides medical solutions in the field of antiviral, cancer, and fatty liver diseases. The products in the pipeline include HCV, HBV, ASC09, and ASC06. It currently has five anti-viral drug discovery and development programs, including two HCV drug candidates near commercial-stage and one HIV drug candidate that has completed a phase IIa clinical trial. Geographically, it operates in Mainland China and other countries.
---
1672 Stock 12 Month Forecast
Average Price Target
HK$3.80
▲(375.00% Upside)
Technical Analysis
Viva Biotech Holdings
―
Million Hope Industries Holdings Ltd.
―
Billion Industrial Holdings Ltd.
―
Top Education Group Ltd.
―
Best Analysts Covering 1672
1 Year
1 Year Success Rate
0/4 ratings generated profit
1 Year Average Return
-50.28%
reiterated a buy rating 3 months ago
Copying Chris Lui's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -50.28% per trade.
---